Professionnals
area
General
public access

Mood disorders

Mood disorders, depression and bipolar disorder affect people of all ages and sometimes cause severe mental distress. Effective treatments exist and ongoing research is evaluating the impact of the intestinal microbiota on these disorders.

According to the World Health Organization (WHO), depression affects more than 350 million people worldwide. It sometimes causes severe mental distress that can lead to suicide and is the first cause of professional and social disability in the world. More women than men are affected1. Mood disorders include depressive and bipolar disorders. 

Perturbed stress responses

Life events, like the loss of a spouse, a job or a separation, are associated with an increased risk of mood disorders. However, vulnerability to depression, which is partly genetic, exists for each individual2 . Thus, each person with a parent who suffers from depression has a two to four times higher risk of having a depressive episode in his/her lifetime. Defective regulation of the stress-response system, with abnormally high secretion of cortisol, the stress hormone, can also induce a depressive state. Lastly, a microbiota–intestine–brain axis communicates via multiple pathways (parasympathetic nervous system, immune, blood) and participates in the pathophysiology of mood disorders3 . Recent research on the intestinal microbiota yielded findings showing associations between dysbiosis and depression.

What treatments? 

Therapy is based on antidepressants combined with cognitive behavioral therapy for depressive disorders and mood-stabilizing drugs2,4 . A microbiota role may be promising. Results of a recent randomized, double-blind, placebo-controlled study showed that daily intake by healthy volunteers of a combination of probiotics—Lactobacillus helveticus and Bifidobacterium longum—improved mood and lowered anxiety levels5.

 

Sources:
1 – OMS, avril 2016, la dépression http://www.who.int/mediacentre/factsheets/fs369/fr/
2 – INSERM, dépression, août 2014, http://www.inserm.fr/thematiques/neurosciences-sciences-cognitives-neurologie-psychiatrie/dossiers-d-information/depression
3 – Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13:701-12.
4 - Haute Autorité de Santé (HAS), décembre 2010, prise en charge d'un trouble bipolaire, http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/ald_23_gp_troublebipolaire_web.pdf
5 -  Messaoudi M et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105:755-64. https://www.ncbi.nlm.nih.gov/pubmed/20974015

Pathologies

  • Alzheimer’s disease

    Alzheimer’s disease is a neurodegenerative disease that seems to start well before symptoms first appear. There is cu...

    Voir
  • Parkinson's disease

    For roughly 15 years, it has been hypothesized that Parkinson’s disease does not originate exclusively in the brain, ...

    Voir
  • Schizophrenia

    Recent hypotheses suggest that an alteration in the microbiota that sustains inflammation could favor schizophrenia. ...

    Voir
  • Multiple sclerosis

    The intestinal microbiota may become a target for therapy in the fight against multiple sclerosis (MS). The results o...

    Voir
  • Anxiety disorders

    The discovery of a role of the intestinal microbiota in anxiety disorders that affect hundreds of millions of individ...

    Voir
  • Autism-Spectrum disorders

    Previously called pediatric schizophrenia, autism-spectrum disorders (ASDs) now include autistic disorders and other ...

    Voir
Newsletter

Enter your email address to subscribe to our Newsletter.

BMI overview

The Biocodex Microbiota Institute: an international leader in microbiota

Voir

Choose the language in which you wish to receive the newsletter